Statistics
The Regencell Bioscience Holdings Limited stock price is currently $ 4.94 with a total market cap valuation of $ 2.45B (495.88M shares outstanding). The Regencell Bioscience Holdings Limited is trading on NASDAQ under the ticker sign RGC. Regencell Bioscience Holdings Limited price is up
Description
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Company Profile
- Full Name: Regencell Bioscience Holdings Limited
- Sector: Healthcare
- Website: https://www.regencellbioscience.com
